Necrotic enteritis (NE) and coccidiosis are common concurrent enteric infections which can negatively impact broiler health and performance. Losses in animal performance due to these diseases cost the global poultry industry more than two billion USD annually.2 Increased incidence of these diseases, especially NE, have been associated with the rapid growth of antibiotic-free (ABF) and no antibiotic ever (NAE) poultry production programs, which are estimated to compose 45-50 percent of commercial poultry flocks in the United States.3-6 Commercial poultry producers now face the daunting challenge to maintain broiler health and performance without antibiotics which have traditionally been used to control enteric bacterial challenges like NE and coccidiosis.